ProCE Banner Activity

The Overlap Between Opioid Use Disorder and Schizophrenia

Clinical Thought

Although substance use is not uncommon in people with schizophrenia, it appears that opioids are not typically the culprit. In this commentary, a psychiatrist specializing in psychotic disorders speculates why this may be.

Released: October 25, 2023

Share

Faculty

Jacob Ballon

Jacob Ballon, MD, MPH

Clinical Professor
Co-Division Chief
Division of General Adult Psychiatry and Psychology
Co-Director, INSPIRE Clinic
Department of Psychiatry and Behavioral Sciences
Stanford University
Stanford, California

Provided by

Provided by Clinical Care Options, LLC, and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.

ProCE Banner

Supporters

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see this link for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA

Opioid Analgesic REMS Program Companies

Partners

Alliance to Advance Comprehensive Integrative Pain Management

ProCE Banner

American Academy of Physical Medicine and Rehabilitation

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner

ProCE

ProCE Banner

Disclosure

Primary Author

Jacob Ballon, MD, MPH

Clinical Professor
Co-Division Chief
Division of General Adult Psychiatry and Psychology
Co-Director, INSPIRE Clinic
Department of Psychiatry and Behavioral Sciences
Stanford University
Stanford, California

Jacob Ballon MD, MPH: consultant/advisor/speaker: Alkermes, Teva.